Popular Brain Supplement Tyrosine Linked to Nearly a Year of Lost Lifespan in Men
A 270,000-person study finds higher blood tyrosine levels associated with shorter lifespans in men, raising concerns about common focus supplements.
Summary
A large study using UK Biobank data found that men with higher blood levels of tyrosine — an amino acid commonly taken in brain and focus supplements — may live nearly a year less than those with lower levels. Researchers analyzed over 270,000 participants and used Mendelian randomization, a genetic technique that strengthens causal inference, to confirm the association. Women showed no such pattern. Tyrosine is widely found in protein-rich foods and sold in supplements marketed for dopamine support, mood, and cognitive performance. While the finding doesn't prove tyrosine directly causes early death, it raises meaningful questions for men who regularly supplement with it and warrants closer scientific attention.
Detailed Summary
A large-scale study published in the journal Aging-US has found a potentially surprising link between the amino acid tyrosine and reduced lifespan in men. Tyrosine is a common ingredient in brain health and nootropic supplements, prized for its role in producing dopamine, norepinephrine, and epinephrine. For health-conscious individuals who supplement for focus, motivation, or stress resilience, this finding introduces an important caveat worth understanding.
Researchers from the University of Hong Kong and the University of Georgia analyzed health and genetic data from over 270,000 participants in the UK Biobank. They used two methods: direct observational analysis of amino acid blood levels versus mortality outcomes, and Mendelian randomization — a genetic approach that uses naturally occurring gene variants to approximate a controlled experiment. This dual approach significantly strengthens the reliability of the association beyond simple correlation.
The key finding was that elevated blood tyrosine levels were consistently associated with shorter lifespans in men, with genetic modeling estimating a reduction of nearly one year of life expectancy. Phenylalanine, a related amino acid and tyrosine precursor, initially showed a similar pattern but did not hold up under more rigorous analysis. Critically, women showed no significant association, possibly related to the observation that men tend to have higher baseline tyrosine levels.
From a practical standpoint, men who regularly supplement with tyrosine — particularly at high doses — may want to reconsider or discuss this with a clinician. The association does not necessarily mean dietary tyrosine from food sources poses the same risk, and causality is not definitively established.
Important caveats remain: this is observational and genetic epidemiology, not a clinical trial. Confounding factors such as diet quality, metabolic health, or underlying conditions that raise tyrosine levels could partly explain the finding. Replication in independent cohorts and mechanistic studies are needed before firm recommendations can be made.
Key Findings
- Higher blood tyrosine levels linked to nearly one year shorter lifespan in men across 270,000 participants.
- Mendelian randomization supports a potential causal relationship, not just correlation, between tyrosine and male lifespan.
- Women showed no significant association between tyrosine levels and lifespan, suggesting a sex-specific effect.
- Phenylalanine, tyrosine's precursor amino acid, did not show a consistent independent link to reduced lifespan.
- Men who supplement with tyrosine for focus or dopamine support may want to reassess dosing with their doctor.
Methodology
This is a research summary reporting on a peer-reviewed study published in Aging-US by researchers from the University of Hong Kong and University of Georgia. Evidence is based on a large observational dataset (UK Biobank, n=270,000+) combined with Mendelian randomization, which increases causal plausibility. The source, Impact Journals LLC, publishes the journal Aging, a credible peer-reviewed outlet in the longevity field.
Study Limitations
Causality is not definitively proven; Mendelian randomization approximates but does not replace a randomized controlled trial. The article does not detail whether supplement users versus food-sourced tyrosine were differentiated in the analysis. Confounders such as metabolic disease, liver function, or diet patterns that raise tyrosine could contribute to the observed effect.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.